QIM
MDCO

Quantitative Investment Management’s Medicines Co MDCO Stock Holding History

Quantitative Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-55,300
Closed -$1.06M – 905
2018
Q4 		$1.06M Buy
+55,300
New +$1.29M 0.05% 274
2017
Q2 		– Sell
-48,100
Closed -$2.35M – 955
2017
Q1 		$2.35M Buy
+48,100
New +$2.19M 0.04% 450
2016
Q3 		– Sell
-8,900
Closed -$299K – 940
2016
Q2 		$299K Buy
+8,900
New +$314K 0.01% 623
2016
Q1 		– Sell
-51,800
Closed -$1.93M – 1007
2015
Q4 		$1.93M Sell
51,800
-95,700
-65% -$3.62M 0.12% 227
2015
Q3 		$5.6M Buy
+147,500
New +$5.18M 0.42% 53
2014
Q1 		– Sell
-5,800
Closed -$223K – 792
2013
Q4 		$223K Sell
5,800
-2,200
-28% -$78.7K 0.02% 493
2013
Q3 		$268K Buy
+8,000
New +$255K 0.02% 461

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Quantitative Investment Management's MDCO Position: Q1 2019 in Review

Quantitative Investment Management sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 55,300 shares — an estimated $1.06M sold.

Quantitative Investment Management first reported a position in MDCO in Q3 2013 and held it in 7 quarters. The position peaked at $5.6M in Q3 2015. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • Quantitative Investment Management reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 55,300 Medicines Co shares in Q1 2019, an estimated $1.06M.
  • Quantitative Investment Management first reported a position in Medicines Co in Q3 2013 and held it in 7 quarters.
  • Quantitative Investment Management's Medicines Co position peaked at $5.6M in Q3 2015.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on Quantitative Investment Management's 13F filing for Q1 2019, filed 15 May 2019.